• Complex business & tech litigator
• Multiple $1bn+ life science litigations
• Former partner, historic NYC IP firm Kenyon & Kenyon
Jerry Canada is the IP Litigation Lead at Rockridge Venture Law®, a Certified B Corp law group and 2019 Best for the World: Community honoree. Jerry’s practice areas include: patent, trademark, and trade secret litigation; general counsel; and, strategic IP portfolio development.
Prior to joining RVL®, Jerry served as Chief IP Strategist to a small biotech developing novel technologies from stem-cell cancer research targeting glioblastoma. Before that, Jerry was a partner within the life science group of historic N.Y.C. firm Kenyon & Kenyon.
Jerry has represented several fortune 500 companies as a litigator and counselor. He is well-versed in a number of industries and technologies including: medical devices and therapies, electrical, agricultural, stem cell therapies, implants (polymer based), apparel/clothing, automobile components, bioplastics, mechanical, aviation and space technology/rocket science.
As a student at UC Berkeley School of Law (Boalt Hal), Jerry received the 1997 Stephen Finney Jamison Award (awarded to top litigation law student). He also served as Co-President of the Berkeley Law Foundation and Co-Director of the Appellate Advocacy program. As an undergrad, Jerry served as Vice President and President of the student government at SUNY Stony Brook where he was an All-American athlete and record holder on the University’s track and field team.
Jerry is also active in many non-profit and community organizations focused on ending generational poverty within families. Recently, he wrote his first novel, obtained a second-degree black belt in martial arts, and coached a national champion high school track athlete .
His portfolio of complex patent litigations includes:
- DR. BRUCE SAFFRAN V. BOSTON SCIENTIFIC CORPORATION
E.D. Texas, 2008 | jury trial ($500+ million verdict)
- BOSTON SCIENTIFIC CORPORATION V. JOHNSON & JOHNSON
Del., 2006 | jury trial (one of three cases in a $1.7 billion settlement)
- LEAPFROG CORPORATION V. FISHER PRICE, INC. AND MATTEL, INC.
Del., 2006 | jury trial (sought $78 million in damages)
- ENZO CORPORATION V. DIGENE CORPORATION
Del., 2005 | settled on eve of trial
- NOVO NORDISK V. BIOTECHNOLOGY GENERAL AND TEVA PHARMACEUTICALS
Del., 2004 | bench trial
- AMGEN V. HOECHST MARION ROUSSEL AND TRANSKARYOTIC THERAPIES
Mass. 2001 | bench trial